Skip to main content
Log in

ECT cost effective for treatment-resistant depression

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Notes

  1. 2013 US dollars

Reference

  • Ross EL, et al. Cost-effectiveness of Electroconvulsive Therapy vs Pharmacotherapy/Psychotherapy for Treatment-Resistant Depression in the United States. JAMA Psychiatry : 9 May 2018. Available from: URL: http://dx.doi.org/10.1001/jamapsychiatry.2018.0768

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

ECT cost effective for treatment-resistant depression. PharmacoEcon Outcomes News 805, 15 (2018). https://doi.org/10.1007/s40274-018-5017-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-018-5017-9

Navigation